<DOC>
	<DOCNO>NCT00195715</DOCNO>
	<brief_summary>To evaluate long-term maintenance response , safety tolerability repeat administration adalimumab subject Crohn 's disease participate successfully complete Protocol M02-404 Protocol M04-691 .</brief_summary>
	<brief_title>Long-term Safety Tolerability Study Adalimumab Subjects With Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject must successfully complete either M02404 ( NCT00077779 ) M04691 ( NCT00105300 ) protocol eligible study Diagnosis Crohn 's disease Willing able give inform consent Diagnosis ulcerative colitis Women pregnant breastfeed Previous history listeria infection untreated tuberculosis Previous history cancer successfully treat skin cancer carcinomainsitu cervix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>